Assessment of HbA1c as a Predictor of Severity in Diabetic Macular Edema
International Journal of Pharmaceutical Quality Assurance · 09.07.2026 · 16 (10)
DOI: 10.25258/ijpqa.16.10.85 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 09.07.2026. Verfasst von Priya Ranjan und 2 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Diabetic macular edema (DME) is a major vision-threatening complication of diabetes mellitus and is closely linked to chronic hyperglycemia. Hemoglobin A1c (HbA1c) reflects long-term glycemic control and may influence the severity of DME.
Aim
To evaluate the correlation between HbA1c levels and the severity of DME in patients with type II diabetes mellitus. Methodology: This prospective hospital-based cross-sectional study included 90 patients with type II diabetes and DME attending the Department of Ophthalmology, Anugrah Narayan Magadh Medical College, Gaya ji, Bihar. Comprehensive ocular examination and HbA1c estimation were performed. Patients were categorized into good (8%) glycemic control groups. Severity of DME was graded clinically. Statistical analysis was done using SPSS version 27.
Results
Most patients had poor glycemic control (42.3%). Moderate (37.8%) and severe DME (33.3%) were common. Severe DME predominated in patients with HbA1c >8% (21/38), while mild DME was more frequent in those with HbA1c
Zitieren
APA
Ranjan, P., Chaudhary, S., & Iqbal, J. (2026). Assessment of HbA1c as a Predictor of Severity in Diabetic Macular Edema. International Journal of Pharmaceutical Quality Assurance, 16(10). https://doi.org/10.25258/ijpqa.16.10.85
Vancouver
Ranjan P, Chaudhary S, Iqbal J. Assessment of HbA1c as a Predictor of Severity in Diabetic Macular Edema. International Journal of Pharmaceutical Quality Assurance. 2026;16(10). doi:10.25258/ijpqa.16.10.85
BibTeX
@article{Ranjan2026,
author = {Ranjan, Priya and Chaudhary, Sushmita and Iqbal, Jawed},
title = {Assessment of HbA1c as a Predictor of Severity in Diabetic Macular Edema},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {16},
number = {10},
doi = {10.25258/ijpqa.16.10.85}
}
EUVIMED